Provenance du réseau au premier degré de Srinivas Rao
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Pastorus, Inc.
 Pastorus, Inc. Pharmaceuticals: GenericHealth Technology Pastorus, Inc. is a biotechnology company based in the United States that is focused on developing improved, patent-protected forms of oxytocin and other drugs to treat autism. Pastorus aims to address the particular need for drugs to treat autism, a disorder that affects over 3 million individuals in the US and tens of millions worldwide. The American company's core team of three physician-neuroscientists, each with over 20 years of industry experience, collaborate with successful experts in regulatory, clinical, manufacturing, and other domains. Recent research has demonstrated the potential to amplify oxytocin's favorable effects with a combination product, for which Pastorus has a pending patent application. The private company was founded by Jim Page and Glenn Cornett, with Glenn Cornett serving as CEO since incorporation.
3
| Private Company | Pharmaceuticals: Generic | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Srinivas Rao via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Yale University | College/University | Doctorate Degree | |
| Yeshiva University | College/University | Undergraduate Degree | |
| University of California San Diego | College/University | Corporate Officer/Principal | |
Sequel Therapeutics, Inc.
 Sequel Therapeutics, Inc. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Sequel Therapeutics, Inc. is a company that develops immunotherapeutic vaccines. The company is based in San Diego, CA. The company was founded by Jay D. Kranzler. Sequel Therapeutics was acquired by Epimmune, Inc. from The Scripps Research Institute on October 18, 1995 for $6.90 million. | Biotechnology | Chief Executive Officer | |
| Glytec Corp. | Chief Executive Officer | ||
Regenovation, Inc.
 Regenovation, Inc. Miscellaneous Commercial ServicesCommercial Services Regenovation, Inc. develops ways to regenerate human tissue. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Chief Executive Officer | |
| AVENUE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
ImmunoBrain Checkpoint Ltd.
 ImmunoBrain Checkpoint Ltd. BiotechnologyHealth Technology ImmunoBrain Checkpoint Ltd. engages in the development of neuroprotective immune therapies for neurodegenerative diseases. The company was founded by Michal Schwartz and Nathan Hevrony in 2015 and is headquartered in Ness Ziona, Israel. | Biotechnology | Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Perception Neuroscience, Inc.
 Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY. | Medical/Nursing Services | Chief Executive Officer | |
Baergic Bio, Inc.
 Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Baergic Bio, Inc. develops therapeutic drugs for the treatment of central nervous system disorders. It offers oncology, rare diseases, and gene therapy. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 13 |
| Canada | 2 |
| Israël | 2 |
Sectorielle
| Health Technology | 8 |
| Consumer Services | 4 |
| Commercial Services | 2 |
| Health Services | 2 |
Opérationnelle
| Chief Executive Officer | 8 |
| Director/Board Member | 7 |
| Chairman | 5 |
| Founder | 4 |
| President | 3 |
Relations les plus connectées
| Insiders | |
|---|---|
| Jay Kranzler | 15 |
| Glenn Cornett | 1 |
| Hannah Page Bell | 1 |
- Bourse
- Insiders
- Srinivas Rao
- Connexions Sociétés
